Nan Shan Life Insurance’s iShares Biotechnology ETF IBB Stock Holding History

Nan Shan Life Insurance’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,500	Closed	-$377K	–	112
2020 Q1	$377K	Sell	3,500 -25,500	-88%	-$2.94M	0.01%	94
2019 Q4	$3.5M	Sell	29,000 -30,000	-51%	-$3.35M	0.11%	77
2019 Q3	$5.87M	Hold	59,000	–	–	0.16%	69
2019 Q2	$6.44M	Hold	59,000	–	–	0.16%	71
2019 Q1	$6.6M	Hold	59,000	–	–	0.13%	79
2018 Q4	$5.69M	Buy	59,000 +15,000	+34%	+$1.59M	0.14%	85
2018 Q3	$5.37M	Buy	+44,000	New	+$5.18M	0.1%	85
2018 Q2	–	Sell	-21,760	Closed	-$2.32M	–	102
2018 Q1	$2.32M	Sell	21,760 -125,465	-85%	-$13.9M	0.05%	92
2017 Q4	$15.7M	Buy	147,225 +19,050	+15%	+$2.04M	0.41%	49
2017 Q3	$14.3M	Buy	+128,175	New	+$13.7M	0.29%	55
2017 Q2	–	Sell	-15,600	Closed	-$1.52M	–	77
2017 Q1	$1.52M	Buy	+15,600	New	+$1.49M	0.04%	74
2016 Q4	–	Sell	-45,000	Closed	-$4.34M	–	71
2016 Q3	$4.34M	Sell	45,000 -201,360	-82%	-$19.2M	0.13%	63
2016 Q2	$21.1M	Buy	246,360 +64,260	+35%	+$5.77M	0.82%	27
2016 Q1	$15.8M	Buy	+182,100	New	+$16.3M	0.69%	33

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nan Shan Life Insurance's IBB Position: Q2 2020 in Review

Nan Shan Life Insurance sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 3,500 shares — an estimated $377K sold.

Nan Shan Life Insurance first reported a position in IBB in Q1 2016 and held it in 14 quarters. The position peaked at $21.1M in Q2 2016. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Nan Shan Life Insurance reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
Nan Shan Life Insurance sold 3,500 iShares Biotechnology ETF shares in Q2 2020, an estimated $377K.
Nan Shan Life Insurance first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 14 quarters.
Nan Shan Life Insurance's iShares Biotechnology ETF position peaked at $21.1M in Q2 2016.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Nan Shan Life Insurance's 13F filing for Q2 2020, filed 14 Aug 2020.